In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Philip Landfield
Home
Contact Us
How to Cite
Get Newsletter
Become a Member
Login
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
Research News
Drug News
Conference News
AD Hypotheses
AlzSWAN
Current Hypotheses
Hypothesis Factory
Forums
Live Discussions
Virtual Conferences
Interviews
Enabling Technologies
Workshops
Research Tools
Compendia
AlzGene
AlzRisk
Antibodies
Biomarkers
Mutations
Protocols
Research Models
Video Gallery
Resources
Bulletin Boards
Conference Calendar
Grants
Jobs
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Companies
Tutorial
Drugs in Clinical Trials
About Alzheimer's
FAQs
Diagnosis
Clinical Guidelines
Tests
Brain Banks
Treatment
Drugs and Therapies
Caregiving
Patient Care
Support Directory
AD Experiences
Member Directory
Researcher Profiles
Institutes and Labs
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Home
:
Community
:
Researcher Profiles
Researcher Profile
RESEARCHER INFORMATION
First Name:
Philip
Last Name:
Landfield
Title:
Professor and chair
Advanced Degrees:
PhD
Affiliation:
University of Kentucky
Department:
Molecular and Biomedical Pharmacology
City:
Lexington
State/Province:
KY
Zip/Postal Code:
40536
Country/Territory:
U.S.A.
Phone:
859-323-5451
Fax:
859-323-1981
Email Address:
Disclosure:
(view policy)
Member reports no financial or other potential conflicts of interest. [Last Modified: 30 September 2005]
View all comments by Philip Landfield
Clinical Interests:
Aging Process, Alzheimer Disease, Tauopathies, Parkinson Disease, Neuromuscular Disorders (ALS, etc.)
Research Focus:
Animal Models, Neuroimmunology, Electrophysiology, Tau/Cytoskeleton, Microscopy, Apoptosis/Cell cycle, Neurobiology, Bioinformatics/Statistics, Brain imaging, DNA microarrays, Drug screening, Molecular and Cell biology
Work Sector(s):
University
What is the greatest void to date in our knowledge of Alzheimer's Disease?
1. The pathogenic triggers
2. The mechanistic sequences of events
3. The relationship to normal aging
What is your leading hypothesis?
The tumor suppressor hypothesis of Alzheimer's disease
What is your fallback position?
Tumor suppresssor activation is an incidental outcome
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Del.icio.us
Digg
Facebook
Google
Newsvine
Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum
Terms of Use
How to Cite
Privacy Policy
Disclaimer
Disclosure
Copyright